These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27528364)

  • 21. Clinical Theranostics Trademark of Exosome in Glioblastoma Metastasis.
    Nag S; Bhattacharya B; Dutta S; Mandal D; Mukherjee S; Anand K; Eswaramoorthy R; Thorat N; Jha SK; Gorai S
    ACS Biomater Sci Eng; 2023 Sep; 9(9):5205-5221. PubMed ID: 37578350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging circulating biomarkers in glioblastoma: promises and challenges.
    Touat M; Duran-Peña A; Alentorn A; Lacroix L; Massard C; Idbaih A
    Expert Rev Mol Diagn; 2015; 15(10):1311-23. PubMed ID: 26394701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
    Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
    Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients.
    Evans SM; Putt M; Yang XY; Lustig RA; Martinez-Lage M; Williams D; Desai A; Wolf R; Brem S; Koch CJ
    J Neurooncol; 2016 Apr; 127(2):391-400. PubMed ID: 26746692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?
    Lefranc F; Le Rhun E; Kiss R; Weller M
    Cancer Treat Rev; 2018 Jul; 68():145-154. PubMed ID: 30032756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.
    Nakano I; Garnier D; Minata M; Rak J
    Semin Cell Dev Biol; 2015 Apr; 40():17-26. PubMed ID: 25721810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
    Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma.
    Šamec N; Zottel A; Videtič Paska A; Jovčevska I
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Belonging to a network--microRNAs, extracellular vesicles, and the glioblastoma microenvironment.
    Godlewski J; Krichevsky AM; Johnson MD; Chiocca EA; Bronisz A
    Neuro Oncol; 2015 May; 17(5):652-62. PubMed ID: 25301812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-derived extracellular vesicles as a platform to identify low-invasive disease biomarkers.
    González E; Falcón-Pérez JM
    Expert Rev Mol Diagn; 2015; 15(7):907-23. PubMed ID: 25948243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small but Fierce: Tracking the Role of Extracellular Vesicles in Glioblastoma Progression and Therapeutic Resistance.
    Schweiger MW; Tannous BA
    Adv Biosyst; 2020 Dec; 4(12):e2000035. PubMed ID: 32881418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic strategies for inhibiting invasion in glioblastoma.
    Drappatz J; Norden AD; Wen PY
    Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomes and extracellular vesicles: the path forward.
    Stahl PD; Raposo G
    Essays Biochem; 2018 May; 62(2):119-124. PubMed ID: 29765006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Dynamics of Interactions Among Immune and Glioblastoma Cells.
    Eder K; Kalman B
    Neuromolecular Med; 2015 Dec; 17(4):335-52. PubMed ID: 26224516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.
    Skog J; Würdinger T; van Rijn S; Meijer DH; Gainche L; Sena-Esteves M; Curry WT; Carter BS; Krichevsky AM; Breakefield XO
    Nat Cell Biol; 2008 Dec; 10(12):1470-6. PubMed ID: 19011622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irradiation of primary human gliomas triggers dynamic and aggressive survival responses involving microvesicle signaling.
    Baulch JE; Geidzinski E; Tran KK; Yu L; Zhou YH; Limoli CL
    Environ Mol Mutagen; 2016 Jun; 57(5):405-15. PubMed ID: 26602180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular vesicles and microvascular pathology: Decoding the active dialogue.
    Hosseini-Beheshti E; Grau GER
    Microcirculation; 2019 Feb; 26(2):e12485. PubMed ID: 29923276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular vesicles as new players in angiogenesis.
    Kholia S; Ranghino A; Garnieri P; Lopatina T; Deregibus MC; Rispoli P; Brizzi MF; Camussi G
    Vascul Pharmacol; 2016 Nov; 86():64-70. PubMed ID: 27013016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesiclemia: counting on extracellular vesicles for glioblastoma patients.
    Sabbagh Q; Andre-Gregoire G; Guevel L; Gavard J
    Oncogene; 2020 Sep; 39(38):6043-6052. PubMed ID: 32801336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.